Genentec, OSI Pharma to pay $67M to resolve Tarceva false claims

Allen Cone SAN FRANCISCO, D.C., June 7 (UPI) -- Pharmaceutical firms Genentech Inc. and OSI Pharmaceuticals LLC will pay $67 million to settle False Claims Act allegations involving cancer drug Tarceva.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.